{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:07:31Z","timestamp":1793236051856,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-024-01654-x","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T20:17:04Z","timestamp":1731874624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Multidrug resistance in urinary E. coli higher in males compared to females"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9590-9319","authenticated-orcid":false,"given":"Narayan","family":"Khanal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8525-4573","authenticated-orcid":false,"given":"Colin H.","family":"Cortie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4219-2302","authenticated-orcid":false,"given":"Chloe","family":"Story","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-9388","authenticated-orcid":false,"given":"Sandra","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-4697","authenticated-orcid":false,"given":"Kylie J.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-1599","authenticated-orcid":false,"given":"Spiros","family":"Miyakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-3488","authenticated-orcid":false,"given":"Caitlin","family":"Keighley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"1","key":"1654_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/qco.0000000000000228","volume":"29","author":"Z Tandogdu","year":"2016","unstructured":"Tandogdu Z, Wagenlehner FME. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73\u20139. https:\/\/doi.org\/10.1097\/qco.0000000000000228.","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"1654_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5414\/cpp42360","volume":"42","author":"E Hummers-Pradier","year":"2004","unstructured":"Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM. Urinary tract infection in men. Int J Clin Pharmacol Ther. 2004;42(7):360\u20136. https:\/\/doi.org\/10.5414\/cpp42360.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"9","key":"1654_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jiac.2021.06.006","volume":"27","author":"JB Choi","year":"2021","unstructured":"Choi JB, Min SK. Complicated urinary tract infection in patients with benign prostatic hyperplasia. J Infect Chemother. 2021;27(9):1284\u20137. https:\/\/doi.org\/10.1016\/j.jiac.2021.06.006.","journal-title":"J Infect Chemother"},{"issue":"16","key":"1654_CR4","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.3390\/jcm12165166","volume":"12","author":"F Bielec","year":"2023","unstructured":"Bielec F, Brauncajs M, Pastuszak-Lewandoska D. Nitrofuran derivatives cross-resistance evidence\u2014uropathogenic Escherichia coli Nitrofurantoin and Furazidin in Vitro susceptibility testing. J Clin Med. 2023;12(16):5166.","journal-title":"J Clin Med"},{"issue":"10","key":"1654_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Reviews Urol. 2020;17(10):586\u2013600. https:\/\/doi.org\/10.1038\/s41585-020-0362-4.","journal-title":"Nat Reviews Urol"},{"issue":"10325","key":"1654_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"issue":"1","key":"1654_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14(1):13. https:\/\/doi.org\/10.1186\/1471-2334-14-13.","journal-title":"BMC Infect Dis"},{"issue":"10014","key":"1654_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(15)00473-0.","journal-title":"Lancet"},{"key":"1654_CR9","doi-asserted-by":"publisher","first-page":"7656752","DOI":"10.1155\/2018\/7656752","volume":"2018","author":"DS Lee","year":"2018","unstructured":"Lee DS, Lee S-J, Choe H-S. Community-acquired urinary tract infection by Escherichia coli in the era of Antibiotic Resistance. Biomed Res Int. 2018;2018:7656752. https:\/\/doi.org\/10.1155\/2018\/7656752.","journal-title":"Biomed Res Int"},{"key":"1654_CR10","doi-asserted-by":"publisher","unstructured":"Poirel L, Madec J-Y, Lupo A, Schink A-K, Kieffer N, Nordmann P, et al. Antimicrobial Resistance in Escherichia coli. Microbiol Spectr. 2018;6(4). https:\/\/doi.org\/10.1128\/microbiolspec.arba-0026-2017.","DOI":"10.1128\/microbiolspec.arba-0026-2017"},{"key":"1654_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jgar.2022.11.008","volume":"31","author":"C Keighley","year":"2022","unstructured":"Keighley C, van Oijen AM, Brentnall SJ, Sanderson-Smith M, Newton P, Miyakis S. Multi-year antimicrobial-resistance trends in urine Escherichia coli isolates from both community-based and hospital-based laboratories of an Australian local health district. J Global Antimicrob Resist. 2022;31:386\u201390. https:\/\/doi.org\/10.1016\/j.jgar.2022.11.008.","journal-title":"J Global Antimicrob Resist"},{"key":"1654_CR12","unstructured":"Guidelines ET. Antibiotic choice for urinary tract infection in adults. 2019. Electronic Therapeutic Guidelines. https:\/\/tgldcdp.tg.org.au.acs.hcn.com.au\/viewTopic?etgAccess=true&guidelinePage=Antibiotic&topicfile=uti-adults-antibiotic-choice&guidelinename=Antibiotic&sectionId=toc_d1e47#toc_d1e47"},{"issue":"11","key":"1654_CR13","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1093\/jac\/dkab212","volume":"76","author":"SJ Ambrose","year":"2021","unstructured":"Ambrose SJ, Hall RM. dfrA trimethoprim resistance genes found in Gram-negative bacteria: compilation and unambiguous numbering. J Antimicrob Chemother. 2021;76(11):2748\u201356. https:\/\/doi.org\/10.1093\/jac\/dkab212.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1654_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","volume":"22","author":"J Strahilevitz","year":"2009","unstructured":"Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22(4):664\u201389.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1654_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2334-13-19","volume":"13","author":"I Linhares","year":"2013","unstructured":"Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000\u20132009). BMC Infect Dis. 2013;13(1):19. https:\/\/doi.org\/10.1186\/1471-2334-13-19.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1654_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.55730\/1300-0144.5641","volume":"53","author":"\u0130 \u015eencan","year":"2023","unstructured":"\u015eencan \u0130, Karabay O, Altay FA, Y\u0131ld\u0131z SS, \u015eim\u015fek H, G\u00f6z\u00fckara MG, et al. Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. Turk J Med Sci. 2023;53(3):780\u201390. https:\/\/doi.org\/10.55730\/1300-0144.5641.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"1654_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2296-14-25","volume":"14","author":"JC McGregor","year":"2013","unstructured":"McGregor JC, Elman MR, Bearden DT, Smith DH. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients. BMC Fam Pract. 2013;14(1):25. https:\/\/doi.org\/10.1186\/1471-2296-14-25.","journal-title":"BMC Fam Pract"},{"issue":"8","key":"1654_CR18","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1086\/383029","volume":"38","author":"ML Wilson","year":"2004","unstructured":"Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis. 2004;38(8):1150\u20138. https:\/\/doi.org\/10.1086\/383029.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1654_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s15010-007-6180-2","volume":"35","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Ross T, Pitout JDD, Church DL, Gregson DB. Community-onset urinary tract infections: a Population-based Assessment. Infection. 2007;35(3):150. https:\/\/doi.org\/10.1007\/s15010-007-6180-2.","journal-title":"Infection"},{"issue":"3","key":"1654_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1654_CR21","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1093\/jac\/dkw054","volume":"71","author":"W Schr\u00f6der","year":"2016","unstructured":"Schr\u00f6der W, Sommer H, Gladstone BP, Foschi F, Hellman J, Evengard B, et al. Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J Antimicrob Chemother. 2016;71(7):1800\u20136. https:\/\/doi.org\/10.1093\/jac\/dkw054.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1654_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cmi.2015.08.019","volume":"22","author":"M Kresken","year":"2016","unstructured":"Kresken M, K\u00f6rber-Irrgang B, Biedenbach DJ, Batista N, Besard V, Cant\u00f3n R, et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect. 2016;22(1):63.e1-.e5 https:\/\/doi.org\/10.1016\/j.cmi.2015.08.019.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1654_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/mdr.2016.0318","volume":"24","author":"T Costa","year":"2018","unstructured":"Costa T, Linhares I, Ferreira R, Neves J, Almeida A. Frequency and Antibiotic Resistance of Bacteria Implicated in community urinary tract infections in North Aveiro between 2011 and 2014. Microb Drug Resist. 2018;24(4):493\u2013504. https:\/\/doi.org\/10.1089\/mdr.2016.0318.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"1654_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1413-8670(12)70291-X","volume":"16","author":"JL Rocha","year":"2012","unstructured":"Rocha JL, Tuon FF, Johnson JR. Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. Brazilian J Infect Dis. 2012;16(2):115\u201321. https:\/\/doi.org\/10.1016\/S1413-8670(12)70291-X.","journal-title":"Brazilian J Infect Dis"},{"issue":"1","key":"1654_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/qco.0000000000000024","volume":"27","author":"FME Wagenlehner","year":"2014","unstructured":"Wagenlehner FME, Weidner W, Pilatz A, Naber KG. Urinary tract infections and bacterial prostatitis in men. Curr Opin Infect Dis. 2014;27(1):97\u2013101. https:\/\/doi.org\/10.1097\/qco.0000000000000024.","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"1654_CR26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.ajic.2021.05.013","volume":"49","author":"TP Lodise","year":"2021","unstructured":"Lodise TP, Chopra T, Nathanson BH, Sulham K. Hospital admission patterns of adult patients with complicated urinary tract infections who present to the hospital by disease acuity and comorbid conditions: how many admissions are potentially avoidable? Am J Infect Control. 2021;49(12):1528\u201334. https:\/\/doi.org\/10.1016\/j.ajic.2021.05.013.","journal-title":"Am J Infect Control"},{"issue":"3","key":"1654_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5495\/wjcid.v10.i3.33","volume":"10","author":"LT Ong","year":"2020","unstructured":"Ong LT. Antibiotics for complicated urinary tract infection and acute pyelonephritis: a systematic review. World J Clin Infect Dis. 2020;10(3):33\u201341. https:\/\/doi.org\/10.5495\/wjcid.v10.i3.33.","journal-title":"World J Clin Infect Dis"},{"issue":"4","key":"1654_CR28","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.1128\/CMR.00003-20","volume":"34","author":"MC Goebel","year":"2021","unstructured":"Goebel MC, Trautner BW, Grigoryan L. The five ds of Outpatient Antibiotic Stewardship for urinary tract infections. Clin Microbiol Rev. 2021;34(4):e00003\u201320. https:\/\/doi.org\/10.1128\/CMR.00003-20.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"1654_CR29","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1093\/jac\/dku282","volume":"69","author":"GV Sanchez","year":"2014","unstructured":"Sanchez GV, Baird AMG, Karlowsky JA, Master RN, Bordon JM. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. J Antimicrob Chemother. 2014;69(12):3259\u201362. https:\/\/doi.org\/10.1093\/jac\/dku282.","journal-title":"J Antimicrob Chemother"},{"key":"1654_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jgar.2018.10.026","volume":"16","author":"O Fasugba","year":"2019","unstructured":"Fasugba O, Das A, Mnatzaganian G, Mitchell BG, Collignon P, Gardner A. Incidence of single-drug resistant, multidrug-resistant and extensively drug-resistant Escherichia coli urinary tract infections: an Australian laboratory-based retrospective study. J Global Antimicrob Resist. 2019;16:254\u20139. https:\/\/doi.org\/10.1016\/j.jgar.2018.10.026.","journal-title":"J Global Antimicrob Resist"},{"issue":"1","key":"1654_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/antibiotics12010169","volume":"12","author":"DR Ibrahim","year":"2023","unstructured":"Ibrahim DR, Dodd CER, Stekel DJ, Meshioye RT, Diggle M, Lister M, et al. Multidrug-resistant ESBL-Producing E. Coli in Clinical samples from the UK. Antibiotics. 2023;12(1):169. https:\/\/doi.org\/10.3390\/antibiotics12010169.","journal-title":"Antibiotics"},{"key":"1654_CR32","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1017\/S0950268822001637","volume":"150","author":"A Cadavid-Restrepo","year":"2022","unstructured":"Cadavid-Restrepo A, Furuya-Kanamori L, Harris PNA, Ling W, Paterson DL. Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis. Epidemiol Infect. 2022;150:e178. https:\/\/doi.org\/10.1017\/S0950268822001637.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"1654_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13756-019-0599-y","volume":"8","author":"T Xiao","year":"2019","unstructured":"Xiao T, Yang K, Zhou Y, Zhang S, Ji J, Ying C, et al. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016. Antimicrob Resist Infect Control. 2019;8(1):144. https:\/\/doi.org\/10.1186\/s13756-019-0599-y.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"1654_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00345-019-02772-0","volume":"38","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang Y, Zhang X, Li J. An evaluation of multidrug-resistant (MDR) bacteria in patients with urinary stone disease: data from a high-volume stone management center. World J Urol. 2020;38(2):425\u201332. https:\/\/doi.org\/10.1007\/s00345-019-02772-0.","journal-title":"World J Urol"},{"key":"1654_CR35","doi-asserted-by":"publisher","unstructured":"Bezabih YM, Bezabih A, Dion M, Batard E, Teka S, Obole A, et al. Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis. JAC-Antimicrobial Resist. 2022;4(3). https:\/\/doi.org\/10.1093\/jacamr\/dlac048.","DOI":"10.1093\/jacamr\/dlac048"},{"issue":"6","key":"1654_CR36","doi-asserted-by":"publisher","first-page":"e12759","DOI":"10.1111\/tid.12759","volume":"19","author":"M Alevizakos","year":"2017","unstructured":"Alevizakos M, Nasioudis D, Mylonakis E. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Disease. 2017;19(6):e12759. https:\/\/doi.org\/10.1111\/tid.12759.","journal-title":"Transpl Infect Disease"},{"issue":"3","key":"1654_CR37","doi-asserted-by":"publisher","first-page":"bjgpopen17X1010","DOI":"10.3399\/bjgpopen17X101097","volume":"1","author":"S Sadler","year":"2017","unstructured":"Sadler S, Holmes M, Ren S, Holden S, Jha S, Thokala P. Cost-effectiveness of antibiotic treatment of uncomplicated urinary tract infection in women: a comparison of four antibiotics. BJGP Open. 2017;1(3):bjgpopen17X101097. https:\/\/doi.org\/10.3399\/bjgpopen17X101097.","journal-title":"BJGP Open"},{"issue":"5","key":"1654_CR38","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International Clinical Practice guidelines for the treatment of Acute Uncomplicated Cystitis and Pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious diseases. Clin Infect Dis. 2011;52(5):e103\u201320. https:\/\/doi.org\/10.1093\/cid\/ciq257.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1654_CR39","doi-asserted-by":"publisher","first-page":"e00862","DOI":"10.1128\/AAC.00862-20","volume":"64","author":"AE Stapleton","year":"2020","unstructured":"Stapleton AE, Wagenlehner FME, Mulgirigama A, Twynholm M. Escherichia coli Resistance to fluoroquinolones in Community-Acquired uncomplicated urinary tract infection in women: a systematic review. Antimicrob Agents Chemother. 2020;64(10):e00862\u201320. https:\/\/doi.org\/10.1128\/AAC.00862-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1654_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/bco2.286","volume":"5","author":"D Thompson","year":"2024","unstructured":"Thompson D, Xu J, Ischia J, Bolton D. Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies. BJUI Compass. 2024;5(1):5\u201311. https:\/\/doi.org\/10.1002\/bco2.286.","journal-title":"BJUI Compass"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01654-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01654-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01654-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T09:03:03Z","timestamp":1731920583000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01654-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01654-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4397577\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained through the ISLHD UOW Joint Human Research Ethics Committee (2019\/ETH03729). As individual patients were not identified, the need for individual informed consent was waived by the same ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}